Life Sciences Tools and Services

ICON

HTHT

Conference Minutes

01179

ICLR

<p>The following are the minutes of Huazhu's 3Q25FY earnings conference call organized by Dolphin Research. For a review of the financial report, please refer to 'Huazhu: Deep Squat and Jump! Huazhu is still the industry leader.'</p>

HWORLD-S

Icon Energy

H World

Eagle Materials

Huazhu (Minutes): Experiential consumption shows significant growth

Charles Rhyee Reiterates Hold Rating on ICON with 2026 Earnings Warning

Michael Cherny Maintains 'Buy' Rating on ICON

Singh Focuses on Healthcare Industry and Recommends Stocks Like Icon

ICON released FY2025 9 Months Earnings on October 22 After-Market EST, actual revenue USD 6.062 B, actual EPS USD 4.2299

ICON released FY2025 Q3 earnings on October 22 After-Market EST, actual revenue USD 2.043 B (forecast USD 1.981 B), actual EPS USD 0.03 (forecast USD 2.384)

Analyst Maintains Buy Rating on Icon Stock

ICON to Release FY2025 Q3 Earnings on October 22 After-Market EST, Forecast Revenue USD 1.982 B, EPS USD 2.376

Coldwell Maintains a Modest Buy Rating on Icon

Hynes Recommends Icon With a Buy Rating

Jefferies analyst downgrades ICON's rating and target price

Icon Updates 2025 Fiscal Year Earnings Guidance

ICON plc Reaffirms 2025 Financial Guidance to Ensure Stakeholder Stability

ICON plc COO to speak at Baird 2025 Global Healthcare Conference

Icon analyst ratings adjusted, bullish price targets

ICON PLC Halts Screening and Dosing for New Subjects

Swiss Bank Raises Icon's Target Price to $240

ICON released FY2025 Semi-Annual earnings on July 23 After-Market (EST), actual revenue USD 4.019 B, actual EPS USD 4.2

ICON released FY2025 Q2 earnings on July 23 After-Market EST, actual revenue USD 2.017 B (forecast USD 1.983 B), actual EPS USD 2.2999 (forecast USD 2.16)

ICON plc Announces Q2 2025 Earnings Report, Revenue Growth of 0.8%

ICON plc Identified as a Leading CRO

Beasley Broadcast

NXG CUSHING MIDSTREAM ENERGY F COM 0.001(S/R 11/12/2025)

HeartBeam

Enveric Biosciences

Biodexa Pharmaceuticals

A SPAC III Acquisition

Irobot

Creative Global Tech

Mawson Infrastructure

Photronics

Niagen Bioscience

ChromaDex

Agilent Tech

Waters

West Pharmaceutical

WuXi Biologics

Medpace

Repligen

Stevanato Group SpA

Cryoport

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio